Annals of Surgical Oncology

, Volume 26, Issue 3, pp 919–920 | Cite as

Reply to: “Multimodal Treatment of Locally Advanced Gastric Cancer: Will the West Meet the East?”, by Marino, Elisabetta et al.

  • Yoshiaki Nakamura
  • Takeharu Yamanaka
  • Kohei ShitaraEmail author
Gastrointestinal Oncology



  1. 1.
    Markar SR, Karthikesalingam A, Jackson D, Hanna GB. Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials: comparison between West and East. Ann Surg Oncol. 2013;20:2328–38.CrossRefGoogle Scholar
  2. 2.
    Bang Y-J, Kim Y-W, Yang H-K, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315–21.CrossRefGoogle Scholar
  3. 3.
    Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  • Yoshiaki Nakamura
    • 1
  • Takeharu Yamanaka
    • 2
  • Kohei Shitara
    • 1
    Email author
  1. 1.Department of Gastroenterology and Gastrointestinal OncologyNational Cancer Center Hospital EastKashiwaJapan
  2. 2.Department of BiostatisticsYokohama City UniversityYokohamaJapan

Personalised recommendations